Skip to main content

Table 1 Correlation between MCCC2 expression and clinicopathological features of CRC patients

From: MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer

Characteristic

MCCC2

Low expression (n = 98)

High expression (n = 112)

p-Value

Age

1

 

0.581

  < 60

54 (55.1)

57 (50.89)

 

  ≥ 60

44 (44.9)

55 (49.12)

 

Gender

  

0.018

 Female

34 (34.7)

58 (51.8)

 

 Male

64 (65.3)

54 (48.2)

 

Location

  

1.000

 Colon

80 (81.6)

91 (81.2)

 

 Rectum

18 (18.4)

21 (18.8)

 

Histological grade

  

0.028

 Well

23 (23.5)

19 (17.0)

 

 Moderately

49 (50.0)

76 (67.9)

 

 Poorly

26 (26.5)

17 (15.2)

 

Depth of invasion

  

0.008

 T1

6 (6.1)

5 (4.5)

 

 T2

10 (10.2)

14 (12.5)

 

 T3

41 (41.8)

24 (21.4)

 

 T4

41 (41.8)

69 (61.6)

 

Lymph node metastasis

 

0.249

 N0

28 (28.6)

41 (36.6)

 

 N1

46 (46.9)

53 (47.3)

 

 N2

24 (24.5)

18 (16.1)

 

Distant metastasis

  

 < 0.001

 M0

30 (30.6)

65 (58.0)

 

 M1

68 (69.4)

47 (42.0)

 

TNM stage

  

0.008

 I

12 (12.2)

12 (10.7)

 

 II

9 (9.2)

21 (18.8)

 

 III

9 (9.2)

32 (28.6)

 

 IV

68 (69.4)

47 (42.0)

 

Vein invasion

  

 < 0.001

 Yes

20 (20.4)

21 (18.8)

 

 No

78 (79.6)

91 (81.2)

 

Nerve invasion

  

0.534

 Yes

29 (29.6)

28 (25.0)

 

 No

69 (70.4)

84 (75.0)

 

Tumor size

  

0.441

  ≤ 5 cm

74 (75.5)

79 (70.5)

 

  > 5 cm

24 (24.5)

33 (29.5)

Â